Full Text View
Tabular View
No Study Results Posted
Related Studies
Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives (HOS)
This study has been completed.
Study NCT00679653   Information provided by Abbott
First Received: March 26, 2008   Last Updated: May 16, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Obesity
Hypertension
More general conditions related to this trial
Body Weight
Cardiovascular Diseases
Nutrition Disorders
Overnutrition
Overweight
Signs and Symptoms
Vascular Diseases
Interventions listed in this trial
sibutramine
verapamil/trandolapril
metoprolol/HCT
felodipine/ramipril
Additional drug interventions recognized in this trial
Antihypertensive Agents
Diltiazem
Felodipine
Metoprolol
Metoprolol succinate
Ramipril
Trandolapril
Verapamil
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Antagonists
Adrenergic beta-Antagonists
Angiotensin-Converting Enzyme Inhibitors
Anti-Arrhythmia Agents
Anti-Obesity Agents
Antidepressive Agents
Appetite Depressants
Autonomic Agents
Calcium Channel Blockers
Cardiovascular Agents
Central Nervous System Agents
Enzyme Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Psychotropic Drugs
Sympatholytics
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Abbott


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services